Navigation Links
Vaccine targeting latent TB enters clinical testing
Date:12/1/2011

including participants with and without latent TB infection. SSI H56-IC31 has been tested in several pre-clinical studies with no safety concerns and has shown efficacy in small animal models administered both before infection and to latently infected animals. The vaccine was also shown to control clinical disease and reactivation in a non-human primate model. This is the first time a South African research institute has led a first-in-human Phase I clinical trial of a new TB vaccine.

"SATVI is delighted to be part of the trial at this early stage, which is testament to the high-regard that the developers have for our TB vaccine clinical research expertise to conduct these crucial early trials in humans," said SATVI Director, Professor Willem Hanekom.

SSI H56-IC31 is being developed for both adolescent and adult populations. The trial has been approved by the Medicines Control Council of South Africa. Preliminary results of this trial are expected at the end of 2012.


'/>"/>
Contact: Annmarie Leadman
aleadman@aeras.org
240-599-3018
Aeras
Source:Eurekalert

Page: 1 2

Related biology news :

1. BWH researchers develop a vaccine prototype stronger than traditional vaccines
2. Award-winning research points toward Alzheimer’s vaccine
3. 21st century vaccines -- innovation in design and rational use
4. Newly identified antibodies may improve pneumonia vaccine design
5. TB vaccine candidate shows early promise
6. Scripps Research scientists create vaccine against heroin high
7. Promising developments in vaccine research, development of a vaginal gel and PrEP lead to calls for a combination of biomedical and non biomedical approaches to HIV prevention policy
8. Discovery of natural antibody brings a universal flu vaccine a step closer
9. Innovative vaccines with nanotechnology
10. Adjuvant combo shows potential for universal influenza vaccine
11. Study shows the HPV vaccine Gardasil doesnt increase disease activity in SLE patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2015)... SYDNEY , May 25, 2015  Australia,s market ... inception stage, although 2014 saw the advent of several ... on 24 April 2015 is expected to ignite interest ... devices in Australia . This in ... the industry and drive new partnerships amongst vendors and ...
(Date:5/22/2015)... , May 22, 2015 ... Market by Solution (2D, 3D, Thermal, Emotion, Forensic), by Software ... User (Government and Utilities, Consumer and Home) - Global ... to grow from $2.77 Billion in 2015 to $6.19 ... Browse 79 market data Tables and   ...
(Date:5/21/2015)... BOSTON , May 21, 2015 ... scientific potential of music for health, today announced a ... (BerkleeICE) . The partnership will center on collaboration on ...  As a first step in the collaboration, The Sync ... course on "Music as Medicine" in the 2015-2016 academic ...
Breaking Biology News(10 mins):Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3
... the womb. Inserting a tiny laser into the mother,s uterus ... twins. Advancing the science that may allow doctors to deliver ... genetic diseases before birth. These are examples of the ... field in maternal-fetal medicine," said pediatric surgeon N. Scott Adzick, ...
... Irvine, Calif., Feb. 16, 2010 Butterfly experts have ... key role in explaining wing color diversity. Now, for the ... theory true at least in nine Heliconius ... to see ultraviolet colors also have UV-yellow pigment on their ...
... of induced pluripotent stem cells is that the all-purpose cells ... stem cells, but without the controversy. However, a new ... of the National Academy of Sciences comparing the ability ... cells of the brain has found that induced cells ...
Cached Biology News:Fetal surgery continues to advance 2Fetal surgery continues to advance 3Fetal surgery continues to advance 4Butterfly vision, wing colors linked, UCI study finds 2Induced neural stem cells: Not quite ready for prime time 2
(Date:5/26/2015)... 26. mája 2015 Kevin Xu ... rodiny prezidentom Barackovi Obamovi a Billovi Clintonovi za ... stratou Dr. Rongxiang Xu , otca Kevina. ... Dr. Xu bol pionier, inovátor, humanitárny ... odhodlanie v oblasti vedy a príkladné vedenie svojej ...
(Date:5/26/2015)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... the company,s Phase IIb trial of ORMD-0801, its oral ... (FDA). The submission was made under the company,s existing ... IIb study of ORMD-0801 for type 2 diabetics is ...
(Date:5/26/2015)... NEW YORK , May 26, 2015 ... NVGN ), announced today that it will present at the ... New York City at the Grand Hyatt ... Kelly , Novogen Chairman and CEO, is scheduled to begin at ... To access the webcast, go to http://wsw.com/webcast/marcum3/nvgn . ...
(Date:5/25/2015)... a science-driven healthcare company seeking to solve some of ... that Dame Marjorie Scardino , Chairman of the ... appointed to PureTech,s Board of Directors in the role ... Joi Ito , MIT Media Lab,s Director, has ... PureTech,s outgoing Chairman and co-founder, former Executive Vice President ...
Breaking Biology Technology:Dr. Rongxiang Xu, O legende 2Oramed Submits Protocol to U.S. FDA for Its Phase IIb Oral Insulin Study 2Oramed Submits Protocol to U.S. FDA for Its Phase IIb Oral Insulin Study 3Novogen to Present at the 2015 Marcum Microcap Conference 2Novogen to Present at the 2015 Marcum Microcap Conference 3Novogen to Present at the 2015 Marcum Microcap Conference 4PureTech Adds Dame Marjorie Scardino to Board of Directors, Names Joi Ito as Chairman of the Board and Expands Management Team 2PureTech Adds Dame Marjorie Scardino to Board of Directors, Names Joi Ito as Chairman of the Board and Expands Management Team 3
... , , , KALAMAZOO, Mich., Sept. ... it will participate in the following investor conferences: , , ... Global Healthcare Unplugged Conference , New York, New York , , ... Global Life Sciences Conference , New York, New York , , ...
... ViroPharma Incorporated (Nasdaq: VPHM ) today announced that ... during the month of September. , , ... present at the Rodman & Renshaw 11th Annual Global Healthcare Conference ... conference is being held at the New York Palace Hotel. , ...
... AURORA, Ontario, Sept. 3 Helix BioPharma Corp. (TSX, FSE: ... and chief operating officer, will present at the Rodman and ... Wednesday, Sept. 9, at the New York Palace Hotel in ... the Company,s leading product development programs L-DOS47 and Topical Interferon ...
Cached Biology Technology:Stryker to Present at Investor Conferences 2ViroPharma to Present at Several Upcoming Healthcare Conferences 2Helix Biopharma to Present at the Rodman & Renshaw 11th Annual Healthcare Conference 2Helix Biopharma to Present at the Rodman & Renshaw 11th Annual Healthcare Conference 3
... easy-to-use kits for arraying proteins of ... common lab equipment. DiscoverLight Protein Array ... your protein, cell lysate or antibody ... kits include specially designed nitrocellulose membranes ...
... formulated specifically for Alkaline Phosphatase conjugates. ... activity for both the enzyme and the ... This product has been chemically engineered ... a longer shelf life, resistance to various ...
Request Info...
NovaScreen offers cell biology, cell culture and molecular biology services for companies who lack a cell culture facility....
Biology Products: